This is the authors' abstract. We don't add key points for this paper.
High-throughput sequencing of circulating cell-free DNA (cfDNA) as liquid biopsy has revolutionized tumor genome profiling by providing a more accurate, longitudinal, real-time and non-invasive mean for precision and personalized medicine. Current knowledge on cfDNA characteristics revealed that it exists mainly as double-stranded molecules, resulting from biological fragmentation into both short (<1 kb) and long segments (>10 kb) [1,2]. Short fractions are mostly derived from apoptosis via the activation of cellular endonucleases leading to the cleavage of chromatin DNA into inter-nucleosomal fragments [3], whereas necrosis generates relatively long fragments of DNA.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chen Yeh (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: